2023上半年营收增长0.7%,营业利润萎缩17.7%,净利润大幅萎缩72.2%。
目前市盈率17.6,市盈率TTM提高...查看全文
药明康德2019-12-04 12:17
▎医药观澜/报道
12月2日,知名网站GEN发布《2019全球免疫肿瘤学初创公司TOP10》,其中包括未上市的癌症免疫疗法企业,该排名按照企业总募资金额进行排名。值得一提的是,天境生物则以3.798亿美元募资额,成为唯一一家上榜的中国免疫肿瘤学初创公司。我们一起来看看,在即将过去的这一年,这1...查看全文
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027141 Size: 6 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-020170 Size: 6 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-020177 Size: 4 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-020130 Size: 6 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-020153 Size: 6 KB 网页链接
$SITE Centers(SITC)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-046202 Act: 34 Size: 178 KB 网页链接
$SITE Centers(SITC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-019352 Act: 34 Size: 22 MB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-017120 Size: 4 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-017131 Size: 5 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-017088 Size: 4 KB 网页链接